Bioperformance Fails To Respond To ERSP Inquiry

New York, NY – June 14, 2006  – The Electronic Retailing Self-Regulation Program (ERSP), announced that BioPerformance Inc., has failed to respond to an initial inquiry regarding core claims made in direct response advertising for its BioPerformance Fuel Enhancement and Wealth Building System.

According to ERSP Policy and Procedures, BioPerformance will be afforded an additional 10 days to submit substantiation for its core claims. If the marketer fails to provide substantiation for its claims, ERSP will refer the matter to the appropriate governmental agency.

Core claims at issue in the ERSP inquiry include:

Establishment claims

  • All this information has been scientifically proven and documented.”

Performance claims

  • “…you can save up to a WHOPPING 25 percent or more over what you’re currently spending on your Gas or Diesel.”
  • “…have generated over $25 million in company sales…Over $16 million dollars have been paid to those who decided to take action and get involved”; “Reduces environmental pollution, maximizes performance, and cleans their fuel system while at the same time saves up to $0.50 and even more on every gallon of their gas and diesel.”
  • “Fuel pill works…increase our fuel economy 25% and more…track record it’s been around since 1989… once you drop this product into your fuel, it becomes a catalyst …and allows for quicker and easier ignition of your fuel…..generate more horse power that you can actually feel in the performance of your vehicle… reduce emission levels by 60-90%”

 Testimonial claims

  • “We just returned from a 2,600 mile trip. When we started we got 11 mpg and now we’re up to 16 mpg using the pills …” and “My Diamante usually gets around 325 miles a tank….I am now getting 425 miles a tank and I am on the 6th tank of using the pills! That’s 100 more miles a tank!”)

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Oral Essentials Discontinue "Certified Non-Toxic" Claim for its Lumineux Mouthwash

New York, NY – December 30, 2024 – In a Fast-Track SWIFT challenge brought by GuruNanda, the National Advertising Division recommended that Oral Essentials discontinue its claim that Lumineux mouthwash products are “Certified Non-Toxic.” 

Read the Decision Summary
Decision

NARB Recommends T-Mobile Discontinue or Modify Commercial to Better Disclose Conditions of Free iPhone Offer, 20% Savings Claim

New York, NY – December 30, 2024 – A panel of the National Advertising Review Board (NARB) recommended that T-Mobile discontinue or modify its commercial to better disclose the material conditions of its free iPhone 16 Pro offer and its 20% rate plan savings claim compared to AT&T and Verizon. 

Read the Decision Summary
Decision

Direct Selling Self-Regulatory Council Recommends Valentus Discontinue Earnings and Product Performance Claims

McLean, VA – December 23, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended Valentus, a direct selling company that sells nutritional and lifestyle products, discontinue earnings and health-related product performance claims made on social media and on the Valentus website.

Read the Decision Summary
Decision

Direct Selling Self-Regulatory Council Refers Olive Tree Earnings Claims to the FTC and California AG for Possible Enforcement Action

McLean, VA – December 20, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) referred Olive Tree to the Federal Trade Commission (FTC) and California Attorney General's Office for possible enforcement action after Olive Tree failed to respond to a DSSRC inquiry into earnings claims.  

Read the Decision Summary